Amphetamine (US brand name Dynavel-XR®) extended-release oral suspension is a central nervous system (CNS) stimulant. Here is more information about this medication.
FDA-approved indications
Treatment of Attention Deficit Hyperactivity Disorder (ADHD)
Dosage
Starting dose: 2.5 mg or 5 mg once daily in the morning (ages 6 or more)
Titration: Increments of 2.5 mg to 10 mg per day every 4 to 7 days until optimal response is obtained
Maximum: 20 mg per day
Dosing Instructions
- Shake bottle before administering the dose
- May be taken with or without food
Switching from other Amphetamine Products
If switching from other amphetamine products, discontinue that treatment, and titrate with Dynavel XR® using the above titration schedule. Do not substitute for other amphetamine products on a milligram-per-milligram basis, because of different amphetamine base compositions and differing pharmacokinetic profiles.
Dosage forms and strengths
Extended-release oral suspension: 2.5 mg amphetamine base per mL
Please refer to Prescribing Information (see link below) for complete discussion of dosage, administration, warnings and precautions, contraindications, etc.
Related Pages
Amphetamine preparations
Tips for prescribing ADHD medications
Converting stimulants: Equivalent doses
Stimulants: Main page (links to all pages on this topic)
References
Prescribing information for amphetamine (Dynavel-XR®) extended-release oral suspension
Copyright 2017, Rajnish Mago, MD. All rights reserved. May not be reproduced in any form without express written permission.
Disclaimer: The content on this website is provided as general education for medical professionals. It is not intended or recommended for patients or other laypersons, or as a substitute for medical advice, diagnosis, or treatment. Patients must always consult a qualified health care professional regarding their diagnosis and treatment. Healthcare professionals should always check this website for the most recently updated information.
Leave a Reply